基于Cox比例风险模型的子痫前期母儿结局分层及预后模型的建立OA
Development of a stratification and prognostic model for maternal and neonatal out-comes in preeclampsia based on Cox proportional hazards modeling
目的:探究子痫前期(PE)母体及新生儿不良结局的独立危险因素,基于Cox比例风险回归模型,构建母体不良结局和新生儿不良结局的分层预测模型,为临床决策PE分娩时机提供参考.方法:回顾性纳入广西医科大学第一附属医院280 例 20~37孕周PE患者的临床资料,分别构建母体不良结局和新生儿不良结局预测模型,根据是否发生不良结局,将患者分为不良结局组及无不良结局组.运用LASSO回归筛选出不良妊娠结局组的独立危险因素,基于Cox比例风险回归构建预测模型.通过受试者工作特征(ROC)曲线下面积(AUC)检测模型预测效能,校准曲线判断模型校准度,借助Bootstrap重复取样法进行内部验证.同时收集另一家医院的 150 例临床数据开展外部验证.结果:母体不良结局预测模型纳入血小板、肌酐、丙氨酸氨基转移酶、入院前收缩压峰值、24h尿蛋白定量、入院时孕周分层,模型C-index为0.701(95%CI:0.63~0.77),在预测期待治疗2、7、14 天的AUC分别为0.791、0.755、0.80.新生儿不良结局预测模型纳入终止时孕周分层、入院时孕天数、胎儿窘迫、入院时平均动脉压、肌酐,模型C-index为0.85(95%CI:0.82~0.87),在预测期待治疗2 天、7 天、14 天AUC分别为0.914、0.95、0.963,内部及外部验证提示两个模型预测性能良好.结论:血小板、肌酐、丙氨酸氨基转移酶、入院前血压收缩压峰值、24h尿蛋白定量、入院时孕周分层是PE母体不良结局的独立危险因素,终止时孕周分层、入院时孕天数、胎儿窘迫、入院时平均动脉压、肌酐是新生儿不良结局的危险因素,构建的PE母体和新生儿不良结局分层预测模型能有效预测不良结局发生风险,指导临床决策分娩时机,降低不良结局风险从而改善围产结局.
Objective:To investigate the independent risk factors for maternal and neo-natal adverse outcomes in preeclampsia,and to construct stratified prediction models for mater-nal and neonatal adverse outcomes based on the Cox proportional hazards model,so as to pro-vide references for the timing of clinical preeclampsia delivery.Methods:A retrospective study was conducted using clinical data from 280 patients with preeclampsia between 20 and 37 weeks of gestation at the First Affiliated Hospital of Guangxi Medical University.Prediction models for maternal and neonatal adverse outcomes were developed separately.Patients were categorized into groups with and without adverse outcomes.Independent risk factors were screened using LASSO(Least Absolute Shrinkage and Selection Operator)regression,and prediction models were constructed based on Cox proportional hazards regression.The predictive performance was evaluated by the area under the curve(AUC)of the receiver operating characteristic(ROC)curve.Calibration was assessed using calibration curves.Internal validation was performed using the bootstrap resampling method,and external validation was conducted on a dataset of 150 ca-ses from another hospital.Results:The maternal adverse outcome prediction model incorporated platelet count,creatinine,alanine aminotransferase,peak systolic blood pressure prior to admis-sion,24-hour urinary protein quantification,and stratified gestational age at admission.The mod-el's C-index was 0.701(95%CI:0.63~0.77).The areas under the curve(AUC)for predic-ting outcomes at 2,7,and 14 days of expectant management were 0.791,0.755,and 0.80,re-spectively.The neonatal adverse outcome prediction model incorporated stratified gestational age at delivery,gestational days at admission,fetal distress,mean arterial pressure at admission,and creatinine.This model achieved a C-index of 0.85(95%CI:0.82~0.87),with AUCs of 0.914,0.95,and 0.963 for predicting outcomes at 2,7,and 14 days of expectant management,respectively.Both internal and external validation indicated good predictive performance for the two models.Conclusion:Platelet count,creatinine,alanine aminotransferase,peak systolic blood pressure prior to admission,24-hour urinary protein quantification,and stratified gestational age at admission are independent risk factors for maternal adverse outcomes in preeclampsia.Strati-fied gestational age at delivery,gestational days at admission,fetal distress,mean arterial pres-sure at admission,and creatinine are risk factors for neonatal adverse outcomes.The constructed stratified prediction models for maternal and neonatal adverse outcomes in PE can effectively predict the risk of adverse outcomes,guide clinical decision-making regarding the timing of de-livery,and thereby reduce the risk of adverse outcomes to improve perinatal outcomes.
何桂宁;龙玉;吴敏;曾雅畅
广西医科大学第一附属医院产科,南宁 530021广西医科大学第一附属医院产科,南宁 530021广西医科大学第一附属医院产科,南宁 530021广西医科大学第一附属医院产科,南宁 530021
医药卫生
COX比例风险模型子痫前期母儿结局分层模型预测模型
Cox proportional hazards regression modelPre-eclampsiaMaternal and neonatal outcomesHierarchical modelPrediction model
《现代妇产科进展》 2026 (3)
173-181,9
广西适宜技术应用项目(No:S2022080)广西医科大学第一附属医院临床研究攀登计划青年科技启明星项目(No:YYZS2023016)国家自然科学基金地区科学基金项目(No:82560310)广西自然科学基金(No:2024GXNSFAA010368)
评论